Home
Technology
Investor Center
News
Contact Us
Contact Us
Please complete all fields marked with *
Anteris Technologies Ltd
Brisbane – Registered Office
T +61 (0)7 3152 3200
F +61 (0)7 3152 3299
Your message has been received, thank you!
Please complete recaptcha verification to send message.
NEWS AND EVENTS
Home
News & Events
Your browser does not support the video tag.
Your browser does not support the video tag.
ProActive Interview - DurAVR™
CEO Wayne Paterson, The valve world is talking about Natural-like aortic valve shape and function of DurAVR THV
Your browser does not support the video tag.
Your browser does not support the video tag.
PCR London Valves: Interview
DurAVR™ THV Impact of Novel Leaflet Design on Hemodynamics and Physiology
Recent Interviews
Proactive - FDA EFS Approval
PCR LV Panel Discussion – Nov 22
TCT MD Panel Discussion – Sept 22
News 9, Interview with Anteris
Presentations
DECK - PCR London Valves: Late Breaking Clinical Trial
DECK - PCR London Valves: Rapid Fire Abstract
VIDEO - 2022 Annual General Meeting
VIDEO - Live in the OR
Articles
We are pleased to announce Perceptive Life Sciences has invested USD 20 million into Anteris - 2 Mar 2022
Anteris Technologies tapped for merger with 'blank check' NASDAQ-lister - 10 Feb 2022
Anteris Technologies' 30-day data from in-human heart valve trial yields promising results - 25 Jan 2022
Anteris Reports Successful Interim Results for the First-in-Human Trial for DurAVR - 24 Jan 2022
CEO Magazine - Spotting Opportunities
Top 10 MedTech Startup